A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy Interventions: Drug: ATL1102 25mg; Drug: ATL1102 50mg; Drug: Placebo Sponsor: Antisense Therapeutics Limited Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials